Susan van den Hof
- High positive predictive value of Xpert in a low rifampicin resistance prevalence settingBy Anete Trajman, Betina Durovni, Valeria Saraceni, Marcelo Cordeiro-Santos, Frank Cobelens and Susan van den HofArticle | Published in 2014 in European Respiratory JournalAnete Trajman1Federal University of Rio de Janeiro, Rio de Janeiro, Brazil2McGill University, Montreal, CanadaBetina Durovni1Federal University of Rio de Janeiro, Rio de Janeiro, Brazil3Health Dept of Rio de Janeiro, Rio de Janeiro, BrazilValeria Saraceni3Health Dept of Rio de Janeiro, Rio de Janeiro, Brazil4Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, BrazilMarcelo Cordeiro-Santos4Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil5Amazonas State University, Manaus, BrazilFrank Cobelens6Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands7KNCV Tuberculosis Foundation, The Hague, The NetherlandsSusan van den Hof6Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands7KNCV Tuberculosis Foundation, The Hague, The Netherlands
- High positive predictive value of Xpert in a low rifampicin resistance prevalence settingBy Anete Trajman, Betina Durovni, Valeria Saraceni, Marcelo Cordeiro-Santos, Frank Cobelens and Susan van den HofAnete Trajman1Federal University of Rio de Janeiro, Rio de Janeiro, Brazil2McGill University, Montreal, CanadaBetina Durovni1Federal University of Rio de Janeiro, Rio de Janeiro, Brazil3Health Dept of Rio de Janeiro, Rio de Janeiro, BrazilValeria Saraceni3Health Dept of Rio de Janeiro, Rio de Janeiro, Brazil4Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, BrazilMarcelo Cordeiro-Santos4Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil5Amazonas State University, Manaus, BrazilFrank Cobelens6Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands7KNCV Tuberculosis Foundation, The Hague, The NetherlandsSusan van den Hof6Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands7KNCV Tuberculosis Foundation, The Hague, The Netherlands
- HIV and multidrug-resistant tuberculosis: overlapping risk factorsBy Susan van den Hof, Aigul Tursynbayeva, Tleukhan Abildaev, Malik Adenov, Svetlana Pak and Shakhimurat IsmailovSusan van den Hof1KNCV Tuberculosis Foundation, The Hague, The Netherlands2Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The NetherlandsAigul Tursynbayeva3KNCV Tuberculosis Foundation, Representative Office for Central Asia, Almaty, KazakhstanTleukhan Abildaev4National Center of Tuberculosis Problem, Almaty, KazakhstanMalik Adenov4National Center of Tuberculosis Problem, Almaty, KazakhstanSvetlana Pak3KNCV Tuberculosis Foundation, Representative Office for Central Asia, Almaty, KazakhstanShakhimurat Ismailov5Global Fund against AIDS, Tuberculosis and Malaria – Tuberculosis Grant Project Implementation Unit, Almaty, Kazakhstan
- The effectiveness of programmatic management of latent tuberculosis infection in the NetherlandsBy Connie Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard De Vries and Susan Van den HofConnie Erkens1Netherlands and Elimination, KNCV Tuberculosis Foundation, The Hague, NetherlandsErika Slump2Respiratory Epidemiology, National Institute for Public Health and the Environment, Bilthoven, NetherlandsMaurits Verhagen3TB Control, Public Health Service (GGD) Limburg-Noord, Roermond, NetherlandsHenrieke Schimmel2Respiratory Epidemiology, National Institute for Public Health and the Environment, Bilthoven, NetherlandsGerard De Vries1Netherlands and Elimination, KNCV Tuberculosis Foundation, The Hague, NetherlandsSusan Van den Hof1Netherlands and Elimination, KNCV Tuberculosis Foundation, The Hague, Netherlands4Center for Poverty-Related Communicable Diseases, Amsterdam Medical Center, Amsterdam, Netherlands
- Monitoring latent tuberculosis infection diagnosis and management in the NetherlandsBy Connie G.M. Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard de Vries, Frank Cobelens and Susan van den HofArticle | Published in 2016 in European Respiratory JournalConnie G.M. Erkens1KNCV Tuberculosis Foundation, The Hague, The NetherlandsErika Slump2Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The NetherlandsMaurits Verhagen3Municipal Public Health Service (GGD) Limburg-Noord, Roermond, The NetherlandsHenrieke Schimmel2Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The NetherlandsGerard de Vries1KNCV Tuberculosis Foundation, The Hague, The Netherlands2Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The NetherlandsFrank Cobelens1KNCV Tuberculosis Foundation, The Hague, The Netherlands4Dept of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, Amsterdam, The NetherlandsSusan van den Hof1KNCV Tuberculosis Foundation, The Hague, The Netherlands4Dept of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
- Monitoring latent tuberculosis infection diagnosis and management in the NetherlandsBy Connie G.M. Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard de Vries, Frank Cobelens and Susan van den HofConnie G.M. Erkens1KNCV Tuberculosis Foundation, The Hague, The NetherlandsErika Slump2Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The NetherlandsMaurits Verhagen3Municipal Public Health Service (GGD) Limburg-Noord, Roermond, The NetherlandsHenrieke Schimmel2Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The NetherlandsGerard de Vries1KNCV Tuberculosis Foundation, The Hague, The Netherlands2Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The NetherlandsFrank Cobelens1KNCV Tuberculosis Foundation, The Hague, The Netherlands4Dept of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, Amsterdam, The NetherlandsSusan van den Hof1KNCV Tuberculosis Foundation, The Hague, The Netherlands4Dept of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.